The various altered neoantigens expressed in PMOD and cancer can adopt escape mechanisms to inhibit the immune response, such as PD-1/PD-L1 (programmed cell death protein 1/programmed death-ligand 1) interaction, maintaining a disorderly progression.7,8. This evidence concerns the gene PDCD1 and cancer.